Boai Nky Pharmaceuticals Stock Filter Stocks by Fundamentals
300109 Stock | 14.79 0.19 1.27% |
Boai NKY Pharmaceuticals fundamentals help investors to digest information that contributes to Boai NKY's financial success or failures. It also enables traders to predict the movement of Boai Stock. The fundamental analysis module provides a way to measure Boai NKY's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boai NKY stock.
Boai | Shares Owned by Institutions |
Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
All Next | Launch Module |
Boai Fundamentals
Return On Equity | 0.11 | ||||
Return On Asset | 0.0651 | ||||
Profit Margin | 0.27 % | ||||
Operating Margin | 0.29 % | ||||
Current Valuation | 7.34 B | ||||
Shares Outstanding | 484.7 M | ||||
Shares Owned By Insiders | 24.98 % | ||||
Shares Owned By Institutions | 5.90 % | ||||
Price To Book | 2.07 X | ||||
Price To Sales | 4.89 X | ||||
Revenue | 1.59 B | ||||
Gross Profit | 690.63 M | ||||
EBITDA | 671.45 M | ||||
Net Income | 485.79 M | ||||
Total Debt | 60.41 M | ||||
Book Value Per Share | 7.23 X | ||||
Cash Flow From Operations | 488.25 M | ||||
Earnings Per Share | 0.79 X | ||||
Target Price | 26.15 | ||||
Number Of Employees | 1.17 K | ||||
Beta | 0.12 | ||||
Market Capitalization | 7.26 B | ||||
Total Asset | 4.02 B | ||||
Retained Earnings | 1.01 B | ||||
Working Capital | 760.05 M | ||||
Annual Yield | 0.07 % | ||||
Net Asset | 4.02 B | ||||
Last Dividend Paid | 0.67 |
About Boai NKY Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Boai NKY Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boai NKY using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boai NKY Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Boai Stock
Boai NKY financial ratios help investors to determine whether Boai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boai with respect to the benefits of owning Boai NKY security.